3rd Capital deploys focused investment strategies through three dedicated funds, each designed around clear investment theses, proven operational playbooks, and long-term growth strategies. This approach provides investors with targeted exposure to high-growth, high-impact healthcare sectors.
The Longevity Wellness Fund capitalizes on the convergence of advanced diagnostics, preventive care, and consumer health. We invest in companies building next-generation testing platforms that combine clinical precision with digital accessibility and market scalability.
Functional medicine laboratories, direct-to-consumer diagnostics, AI-driven analytics platforms
Acquire and consolidate leading laboratory operators and diagnostic platforms
Proprietary growth methodology combining medical-grade testing with consumer-focused user experience
Growth equity and consolidation opportunities
North America and Europe
The Global Hospital Fund acquires, modernizes, and scales rural and community hospitals, beginning in the United States with planned global expansion. Our strategy combines strategic capital deployment with comprehensive operational transformation, creating value while expanding healthcare access.
Rural hospitals in stable communities currently owned by City or County Governments.
Acquire, capitalize and consolidate up to 50 rural hospitals under one set of systems and controls
Highly experienced Executive Team along with state-of-the-art Management Systems
Growth equity and consolidation opportunities
North America, Europe, Middle East and Asia
The HealthTech & BioTech Fund supports innovators developing cutting-edge medical technologies and therapeutic solutions. From AI-enhanced diagnostics to advanced therapeutics, we invest in companies reshaping healthcare delivery and disease treatment.
Healthcare Technology, Medical Device and BioTech companies with experienced Management and scalable products
Make investments in companies which will benefit from synergy across our portfolio and accelerate growth
Very deep HealthTech and BioTech knowledge and experience across our Senior Team
Growth equity and M&A opportunities
North America, Europe, Asia and The Middle East